Tech Company Financing Transactions
Methylation Sciences Funding Round
Inventages Venture Capital and Quark Venture joined a $30 million funding round for Methylation Sciences. This venture round was announced on 10/7/2016.
Transaction Overview
Company Name
Announced On
10/7/2016
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Quark Venture (Karimah Sabar)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15300 Croydon Dr. 300
Surrey BC, V3S 0Z5
Canada
Surrey BC, V3S 0Z5
Canada
Phone
Website
Email Address
Overview
Methylation Sciences (MSI) is focused on developing new products based on molecules, which have clinical proof of concept but have yet to be exploited in the major pharmaceutical markets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Steven Targum
President
David MacDonald
Browse more venture capital transactions:
Prev: 10/7/2016: WellTok venture capital transaction
Next: 10/7/2016: Gridco Systems venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs